Update in Pediatric Nephrology



Pediatric nephrology has rapidly evolved over the last several decades, with major advances in the pathophysiology, genetics, diagnosis, and treatment of children with kidney diseases. In the post-vaccination era urinary tract infections have become an important cause of serious bacterial infection in childhood, and children with underlying congenital abnormalities of the kidney and urological tract (CAKUT), including those with vesicoureteral reflux, are known to be a high risk group. Recent controversies on the appropriate diagnostic workup of children with febrile UTIs and the decision to prescribe long-term antibiotic prophylaxis in the changing landscape of increased antimicrobial resistance have sparked a lively debate in the medical community on appropriate management strategies. Improved understanding of the molecular mechanisms and genetic risk factors underlying glomerulonephritis have resulted in more rational therapeutics with immunosuppressant medications and rapidly expanding treatment options. With refined therapeutics, increasing survival of chronic illnesses, and technological advances in hospital and critical care medicine also come the growing awareness of the increased risk of acute kidney injury in hospitalized children. The economic and social burden of chronic kidney disease remains substantial in children, although much progress has been made in identifying factors associated with CKD progression and better management of various co-morbid conditions. The epidemiology, diagnosis, and management of childhood hypertension has changed greatly in the last decade, in part fueled by the rising obesity epidemic. Some of the most exciting recent breakthroughs in pediatric nephrology have been in the genetics of kidney development and disease. Emerging tools of next generation sequencing and whole exome sequencing have revolutionized the understanding of the genotype-phenotype associations underlying many pediatric kidney disorders and already have started to transform routine clinical management. Despite these impressive advances much work remains to be done, with the hope for progress to tailor therapies to individual patients based on their underlying molecular genetics in the coming era of personalized medicine.


Pediatric nephrology urinary tract infection Vesicoureteral reflux IgA nephropathy Post-streptococcal glomerulonephritis Henoch-Schonlein Purpura acute kidney injury hypertension chronic kidney disease nephrolithiasis 


  1. Aggarwal A, Kumar P, Chowdhary G, Majumdar S, Narang A. Evaluation of renal functions in asphyxiated newborns. J Trop Pediatr. 2005;51(5):295–9.PubMedGoogle Scholar
  2. Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007;71(10):1028–35.PubMedGoogle Scholar
  3. Andrassy KM. Comments on ‘KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease'. Kidney Int. 2013;84(3):622–3.PubMedGoogle Scholar
  4. Ariceta G, Besbas N, Johnson S, Karpman D, Landau D, Licht C, et al. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol. 2009;24(4):687–96.PubMedGoogle Scholar
  5. Bailey D, Phan V, Litalien C, Ducruet T, Merouani A, Lacroix J, et al. Risk factors of acute renal failure in critically ill children: a prospective descriptive epidemiological study. Pediatr Crit Care Med. 2007;8(1):29–35.PubMedGoogle Scholar
  6. Bajracharya P, Jain A, Baracco R, Mattoo TK, Kapur G. Atypical hemolytic uremic syndrome: a clinical conundrum. Pediatr Nephrol. 2016;31(10):1615–24.PubMedGoogle Scholar
  7. Basu RK, Devarajan P, Wong H, Wheeler DS. An update and review of acute kidney injury in pediatrics. Pediatr Crit Care Med. 2011;12(3):339–47.PubMedGoogle Scholar
  8. Basu RK, Kaddourah A, Terrell T, Mottes T, Arnold P, Jacobs J, et al. Assessment of worldwide acute kidney injury, renal angina and epidemiology in critically ill children (AWARE): study protocol for a prospective observational study. BMC Nephrol. 2015;16:24.PubMedPubMedCentralGoogle Scholar
  9. Bell LE, Mattoo TK. Update on childhood urinary tract infection and vesicoureteral reflux. Semin Nephrol. 2009;29(4):349–59.PubMedGoogle Scholar
  10. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute dialysis quality initiative w. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204–12.PubMedPubMedCentralGoogle Scholar
  11. Blackwell T. World’s most expensive drug—which costs up to $700,000 per year—too expensive. Can Natl Post. 2015;3:2015.Google Scholar
  12. Brandstrom P, Esbjorner E, Herthelius M, Swerkersson S, Jodal U, Hansson S. The Swedish reflux trial in children: III. Urinary tract infection pattern. J Urol. 2010;184(1):286–91.PubMedGoogle Scholar
  13. Brandstrom P, Jodal U, Sillen U, Hansson S. The Swedish reflux trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. J Pediatr Urol. 2011;7(6):594–600.PubMedGoogle Scholar
  14. Bucholz EM, Whitlock RP, Zappitelli M, Devarajan P, Eikelboom J, Garg AX, et al. Cardiac biomarkers and acute kidney injury after cardiac surgery. Pediatrics. 2015;135(4):e945–56.PubMedPubMedCentralGoogle Scholar
  15. Cachofeiro V, Goicochea M, de Vinuesa SG, Oubina P, Lahera V, Luno J. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl. 2008;111:S4–9.Google Scholar
  16. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685–94.PubMedGoogle Scholar
  17. Carmody JB, Charlton JR. Short-term gestation, long-term risk: prematurity and chronic kidney disease. Pediatrics. 2013;131(6):1168–79.PubMedGoogle Scholar
  18. Chand DH, Rhoades T, Poe SA, Kraus S, Strife CF. Incidence and severity of vesicoureteral reflux in children related to age, gender, race and diagnosis. J Urol. 2003;170(4 Pt 2):1548–50.PubMedGoogle Scholar
  19. Chesney RW. The development of pediatric nephrology. Pediatr Res. 2002;52(5):770–8.PubMedGoogle Scholar
  20. Chou HH, Chiou YY, Hung PH, Chiang PC, Wang ST. Omega-3 fatty acids ameliorate proteinuria but not renal function in IgA nephropathy: a meta-analysis of randomized controlled trials. Nephron Clin Pract. 2012;121(1–2):c30–5.PubMedGoogle Scholar
  21. Clark JA, Lieh-Lai MW, Sarnaik A, Mattoo TK. Discrepancies between direct and indirect blood pressure measurements using various recommendations for arm cuff selection. Pediatrics. 2002;110(5):920–3.PubMedGoogle Scholar
  22. Conway PH, Cnaan A, Zaoutis T, Henry BV, Grundmeier RW, Keren R. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA. 2007;298(2):179–86.PubMedGoogle Scholar
  23. Coulthard MG. Vesicoureteric reflux is not a benign condition. Pediatr Nephrol. 2009;24(2):227–32.PubMedGoogle Scholar
  24. Craig JC, Simpson JM, Williams GJ, Lowe A, Reynolds GJ, McTaggart SJ, et al. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med. 2009;361(18):1748–59.PubMedGoogle Scholar
  25. Daniels SR, Loggie JM, Khoury P, Kimball TR. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation. 1998;97(19):1907–11.PubMedGoogle Scholar
  26. Davin JC, Coppo R. Henoch-Schonlein purpura nephritis in children. Nat Rev Nephrol. 2014;10(10):563–73.PubMedGoogle Scholar
  27. Deen PM, Verdijk MA, Knoers NV, Wieringa B, Monnens LA, van Os CH, et al. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science. 1994;264(5155):92–5.PubMedGoogle Scholar
  28. Din-Dzietham R, Liu Y, Bielo MV, Shamsa F. High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation. 2007;116(13):1488–96.PubMedGoogle Scholar
  29. Dummer PD, Limou S, Rosenberg AZ, Heymann J, Nelson G, Winkler CA, et al. APOL1 kidney disease risk variants: an evolving landscape. Semin Nephrol. 2015;35(3):222–36.PubMedPubMedCentralGoogle Scholar
  30. Elder JS. Guidelines for consideration for surgical repair of vesicoureteral reflux. Curr Opin Urol. 2000;10(6):579–85.PubMedGoogle Scholar
  31. Expert Panel on Integrated Guidelines for Cardiovascular H, Risk Reduction in C, Adolescents, National Heart L, Blood I. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(Suppl 5):S213–56.Google Scholar
  32. Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE. Biomarkers in chronic kidney disease: a review. Kidney Int. 2011;80(8):806–21.PubMedGoogle Scholar
  33. Fernbach SK, Maizels M, Conway JJ. Ultrasound grading of hydronephrosis: introduction to the system used by the society for fetal urology. Pediatr Radiol. 1993;23(6):478–80.PubMedGoogle Scholar
  34. Flores FX, Brophy PD, Symons JM, Fortenberry JD, Chua AN, Alexander SR, et al. Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group. Pediatr Nephrol. 2008;23(4):625–30.PubMedGoogle Scholar
  35. Flynn J. The changing face of pediatric hypertension in the era of the childhood obesity epidemic. Pediatr Nephrol. 2013;28(7):1059–66.PubMedGoogle Scholar
  36. Flynn JT, Mitsnefes M, Pierce C, Cole SR, Parekh RS, Furth SL, et al. Blood pressure in children with chronic kidney disease: a report from the chronic kidney disease in children study. Hypertension. 2008;52(4):631–7.PubMedPubMedCentralGoogle Scholar
  37. Flynn JT, Daniels SR, Hayman LL, Maahs DM, McCrindle BW, Mitsnefes M, et al. Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension. 2014;63(5):1116–35.PubMedPubMedCentralGoogle Scholar
  38. Fonseca FF, Tanno FY, Nguyen HT. Current options in the management of primary vesicoureteral reflux in children. Pediatr Clin N Am. 2012;59(4):819–34.Google Scholar
  39. Foster BJ, Khoury PR, Kimball TR, Mackie AS, Mitsnefes M. New reference centiles for left ventricular mass relative to lean body mass in children. J Am Soc Echocardiogr. 2016;29(5):441–7. e2PubMedGoogle Scholar
  40. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360(9341):1197–202.PubMedGoogle Scholar
  41. Garin EH, Araya CE. Treatment of systemic hypertension in children and adolescents. Curr Opin Pediatr. 2009;21(5):600–4.PubMedGoogle Scholar
  42. Garin EH, Olavarria F, Garcia Nieto V, Valenciano B, Campos A, Young L. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics. 2006;117(3):626–32.PubMedGoogle Scholar
  43. Gauthier M, Gouin S, Phan V, Gravel J. Association of malodorous urine with urinary tract infection in children aged 1 to 36 months. Pediatrics. 2012;129(5):885–90.PubMedGoogle Scholar
  44. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342(20):1478–83.PubMedGoogle Scholar
  45. Graves JW, Althaf MM. Utility of ambulatory blood pressure monitoring in children and adolescents. Pediatr Nephrol. 2006;21(11):1640–52.PubMedGoogle Scholar
  46. Grignon A, Filion R, Filiatrault D, Robitaille P, Homsy Y, Boutin H, et al. Urinary tract dilatation in utero: classification and clinical applications. Radiology. 1986;160(3):645–7.PubMedGoogle Scholar
  47. Groothoff J, Gruppen M, de Groot E, Offringa M. Cardiovascular disease as a late complication of end-stage renal disease in children. Perit Dial Int. 2005;25(Suppl 3):S123–6.PubMedGoogle Scholar
  48. Group ET, Wuhl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med. 2009;361(17):1639–50.Google Scholar
  49. Gruppo RA, Rother RP. Eculizumab for congenital atypical hemolytic-uremic syndrome. N Engl J Med. 2009;360(5):544–6.PubMedGoogle Scholar
  50. Hanna MH, Dalla Gassa A, Mayer G, Zaza G, Brophy PD, Gesualdo L, et al. The nephrologist of tomorrow: towards a kidney-omic future. Pediatr Nephrol. 2016;32(3):393–404.PubMedGoogle Scholar
  51. Hannula A, Venhola M, Perhomaa M, Pokka T, Renko M, Uhari M. Imaging the urinary tract in children with urinary tract infection. Acta Paediatr. 2011;100(12):e253–9.PubMedGoogle Scholar
  52. Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol. 2012;27(3):363–73.PubMedGoogle Scholar
  53. Heeringa SF, Chernin G, Chaki M, Zhou W, Sloan AJ, Ji Z, et al. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest. 2011;121(5):2013–24.PubMedPubMedCentralGoogle Scholar
  54. Hildebrandt F, Otto E. Cilia and centrosomes: a unifying pathogenic concept for cystic kidney disease? Nat Rev Genet. 2005;6(12):928–40.PubMedGoogle Scholar
  55. Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, et al. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics. 2007;119(4):e907–19.PubMedGoogle Scholar
  56. Hiraki LT, Feldman CH, Liu J, Alarcon GS, Fischer MA, Winkelmayer WC, et al. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum. 2012;64(8):2669–76.PubMedPubMedCentralGoogle Scholar
  57. Hoberman A, Wald ER, Hickey RW, Baskin M, Charron M, Majd M, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics. 1999;104(1 Pt 1):79–86.PubMedGoogle Scholar
  58. Hoberman A, Charron M, Hickey RW, Baskin M, Kearney DH, Wald ER. Imaging studies after a first febrile urinary tract infection in young children. N Engl J Med. 2003;348(3):195–202.PubMedGoogle Scholar
  59. Hogg RJ. IgA nephropathy: clinical features and natural history—a pediatric perspective. Am J Kidney Dis. 1988;12(5):358–61.PubMedGoogle Scholar
  60. Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, et al. National kidney foundation's kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics. 2003;111(6 Pt 1):1416–21.PubMedGoogle Scholar
  61. Hui-Stickle S, Brewer ED, Goldstein SL. Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis. 2005;45(1):96–101.PubMedGoogle Scholar
  62. Investigators RT, Hoberman A, Greenfield SP, Mattoo TK, Keren R, Mathews R, et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med. 2014;370(25):2367–76.Google Scholar
  63. Ismaili K, Avni FE, Hall M, Brussels Free University Perinatal Nephrology Study G. Results of systematic voiding cystourethrography in infants with antenatally diagnosed renal pelvis dilation. J Pediatr. 2002;141(1):21–4.PubMedGoogle Scholar
  64. Kamei K, Ogura M, Sato M, Ito S, Ishikura K. Evolution of IgA nephropathy into anaphylactoid purpura in six cases-further evidence that IgA nephropathy and Henoch-Schonlein purpura nephritis share common pathogenesis. Pediatr Nephrol. 2016;31(5):779–85.PubMedGoogle Scholar
  65. Kist-van Holthe JE, van Zwet JM, Brand R, van Weel MH, Vossen JM, van der Heijden AJ. Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. Bone Marrow Transplant. 1998;22(6):559–64.PubMedGoogle Scholar
  66. La Scola C, De Mutiis C, Hewitt IK, Puccio G, Toffolo A, Zucchetta P, et al. Different guidelines for imaging after first UTI in febrile infants: yield, cost, and radiation. Pediatrics. 2013;131(3):e665–71.PubMedGoogle Scholar
  67. Lafrance JP, Levin A. Defining AKI: closer to getting the math right. Nephrol Dial Transplant. 2013;28(6):1340–2.PubMedGoogle Scholar
  68. Lameire N, Van Biesen W, Vanholder R. Epidemiology of acute kidney injury in children worldwide, including developing countries. Pediatr Nephrol. 2016;32(8):1301–14.PubMedGoogle Scholar
  69. Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tamminen-Mobius TE. International system of radiographic grading of vesicoureteric reflux. International reflux study in children. Pediatr Radiol. 1985;15(2):105–9.PubMedGoogle Scholar
  70. Lee RS, Cendron M, Kinnamon DD, Nguyen HT. Antenatal hydronephrosis as a predictor of postnatal outcome: a meta-analysis. Pediatrics. 2006;118(2):586–93.PubMedGoogle Scholar
  71. Lendvay TS, Sorensen M, Cowan CA, Joyner BD, Mitchell MM, Grady RW. The evolution of vesicoureteral reflux management in the era of dextranomer/hyaluronic acid copolymer: a pediatric health information system database study. J Urol. 2006;176(4 Pt 2):1864–7.PubMedGoogle Scholar
  72. Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, et al. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2016;31(1):15–39.PubMedGoogle Scholar
  73. Lurbe E, Alvarez J, Redon J. Diagnosis and treatment of hypertension in children. Curr Hypertens Rep. 2010;12(6):480–6.PubMedGoogle Scholar
  74. Lv J, Xu D, Perkovic V, Ma X, Johnson DW, Woodward M, et al. Corticosteroid therapy in IgA nephropathy. J Am Soc Nephrol. 2012;23(6):1108–16.PubMedPubMedCentralGoogle Scholar
  75. MacNeily AE, Afshar K. Screening asymptomatic siblings for vesicoureteral reflux: sound science or religious rhetoric? Can J Urol. 2006;13(6):3309–16.PubMedGoogle Scholar
  76. Mammen C, Al Abbas A, Skippen P, Nadel H, Levine D, Collet JP, et al. Long-term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study. Am J Kidney Dis. 2012;59(4):523–30.PubMedGoogle Scholar
  77. May AL, Kuklina EV, Yoon PW. Prevalence of cardiovascular disease risk factors among US adolescents, 1999–2008. Pediatrics. 2012;129(6):1035–41.PubMedGoogle Scholar
  78. McDonald SP, Craig JC. Australian, New Zealand Paediatric Nephrology A. Long-term survival of children with end-stage renal disease. N Engl J Med. 2004;350(26):2654–62.PubMedGoogle Scholar
  79. McLorie GA, McKenna PH, Jumper BM, Churchill BM, Gilmour RF, Khoury AE. High grade vesicoureteral reflux: analysis of observational therapy. J Urol. 1990;144(2 Pt 2):537–40. discussion 45PubMedGoogle Scholar
  80. Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int. 2004;66(4):1613–21.PubMedGoogle Scholar
  81. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.PubMedPubMedCentralGoogle Scholar
  82. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hara A, et al. Prognostic significance of night-time, early morning, and daytime blood pressures on the risk of cerebrovascular and cardiovascular mortality: the Ohasama Study. J Hypertens. 2006;24(9):1841–8.PubMedGoogle Scholar
  83. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365(9466):1231–8.PubMedGoogle Scholar
  84. Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, et al. Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol. 2010;21(1):137–44.PubMedPubMedCentralGoogle Scholar
  85. Montini G, Rigon L, Zucchetta P, Fregonese F, Toffolo A, Gobber D, et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics. 2008a;122(5):1064–71.PubMedGoogle Scholar
  86. Montini G, Malaventura C, Salviati L. Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N Engl J Med. 2008b;358(26):2849–50.PubMedGoogle Scholar
  87. Montini G, Tullus K, Hewitt I. Febrile urinary tract infections in children. N Engl J Med. 2011;365(3):239–50.PubMedGoogle Scholar
  88. Mori R, Lakhanpaul M, Verrier-Jones K. Diagnosis and management of urinary tract infection in children: summary of NICE guidance. BMJ. 2007;335(7616):395–7.PubMedPubMedCentralGoogle Scholar
  89. Muntner P, He J, Cutler JA, Wildman RP, Whelton PK. Trends in blood pressure among children and adolescents. JAMA. 2004;291(17):2107–13.PubMedGoogle Scholar
  90. Nagler EV, Williams G, Hodson EM, Craig JC. Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev. 2011;6:CD001532.Google Scholar
  91. Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child. 2005;90(9):916–20.PubMedPubMedCentralGoogle Scholar
  92. National High Blood Pressure Education Program Working Group on High Blood Pressure in C, Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555–76.Google Scholar
  93. Ng DK, Robertson CC, Woroniecki RP, Limou S, Gillies CE, Reidy KJ, et al. APOL1-associated glomerular disease among African-American children: a collaboration of the chronic kidney disease in children (CKiD) and nephrotic syndrome study network (NEPTUNE) cohorts. Nephrol Dial Transplant. 2017;32(6):983–90.PubMedGoogle Scholar
  94. Nguyen HT, Benson CB, Bromley B, Campbell JB, Chow J, Coleman B, et al. Multidisciplinary consensus on the classification of prenatal and postnatal urinary tract dilation (UTD classification system). J Pediatr Urol. 2014;10(6):982–98.PubMedGoogle Scholar
  95. Nurnberger J, Philipp T, Witzke O, Opazo Saez A, Vester U, Baba HA, et al. Eculizumab for atypical hemolytic-uremic syndrome. N Engl J Med. 2009;360(5):542–4.PubMedGoogle Scholar
  96. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106(1):100–5.PubMedGoogle Scholar
  97. Omoloja A, Jerry-Fluker J, Ng DK, Abraham AG, Furth S, Warady BA, et al. Secondhand smoke exposure is associated with proteinuria in children with chronic kidney disease. Pediatr Nephrol. 2013;28(8):1243–51.PubMedPubMedCentralGoogle Scholar
  98. O'Rourke MF, Adji A. Clinical use of applanation tonometry: hope remains in Pandora's box. J Hypertens. 2010;28(2):229–33.PubMedGoogle Scholar
  99. Parekh RS, Carroll CE, Wolfe RA, Port FK. Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr. 2002;141(2):191–7.PubMedGoogle Scholar
  100. Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, et al. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med. 2013;369(23):2183–96.PubMedPubMedCentralGoogle Scholar
  101. Passerotti CC, Kalish LA, Chow J, Passerotti AM, Recabal P, Cendron M, et al. The predictive value of the first postnatal ultrasound in children with antenatal hydronephrosis. J Pediatr Urol. 2011;7(2):128–36.PubMedGoogle Scholar
  102. Pennesi M, Travan L, Peratoner L, Bordugo A, Cattaneo A, Ronfani L, et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics. 2008;121(6):e1489–94.PubMedGoogle Scholar
  103. Peters CA, Skoog SJ, Arant BS Jr, Copp HL, Elder JS, Hudson RG, et al. Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol. 2010;184(3):1134–44.PubMedGoogle Scholar
  104. Prelog M, Schiefecker D, Fille M, Wurzner R, Brunner A, Zimmerhackl LB. Febrile urinary tract infection in children: ampicillin and trimethoprim insufficient as empirical mono-therapy. Pediatr Nephrol. 2008;23(4):597–602.PubMedGoogle Scholar
  105. Reeders ST, Breuning MH, Davies KE, Nicholls RD, Jarman AP, Higgs DR, et al. A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature. 1985;317(6037):542–4.PubMedGoogle Scholar
  106. Reid S, Cawthon PM, Craig JC, Samuels JA, Molony DA, Strippoli GF. Non-immunosuppressive treatment for IgA nephropathy. Cochrane Database Syst Rev. 2011;3:CD003962.Google Scholar
  107. Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int. 2008;73(5):538–46.PubMedGoogle Scholar
  108. Roberts KB, Finnell SM, Downs SM. Response to the AAP section on urology concerns about the AAP urinary tract infection guideline. Pediatrics. 2012;129(4):e1054–6.PubMedGoogle Scholar
  109. Rodenbach KE, Schneider MF, Furth SL, Moxey-Mims MM, Mitsnefes MM, Weaver DJ, et al. Hyperuricemia and progression of CKD in children and adolescents: the chronic kidney disease in children (CKiD) cohort study. Am J Kidney Dis. 2015;66(6):984–92.PubMedPubMedCentralGoogle Scholar
  110. Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, et al. Early prednisone therapy in Henoch-Schonlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2006;149(2):241–7.PubMedGoogle Scholar
  111. Rosenthal W, Seibold A, Antaramian A, Lonergan M, Arthus MF, Hendy GN, et al. Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature. 1992;359(6392):233–5.PubMedGoogle Scholar
  112. Sadowski CE, Lovric S, Ashraf S, Pabst WL, Gee HY, Kohl S, et al. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2015;26(6):1279–89.PubMedGoogle Scholar
  113. Samuels J, Ng D, Flynn JT, Mitsnefes M, Poffenbarger T, Warady BA, et al. Ambulatory blood pressure patterns in children with chronic kidney disease. Hypertension. 2012;60(1):43–50.PubMedPubMedCentralGoogle Scholar
  114. Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R, Bragg-Gresham J, et al. US renal data system 2014 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2015;65(6 Suppl 1):A7.Google Scholar
  115. Saran R, Li Y, Robinson B, Abbott KC, Agodoa LY, Ayanian J, et al. US renal data system 2015 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2016;67(3 Suppl 1):A7–8.Google Scholar
  116. Schiffl H, Lang SM. Update on biomarkers of acute kidney injury: moving closer to clinical impact? Mol Diagn Ther. 2012;16(4):199–207.PubMedGoogle Scholar
  117. Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20(3):629–37.PubMedPubMedCentralGoogle Scholar
  118. Selewski DT, Symons JM. Acute kidney injury. Pediatr Rev. 2014;35(1):30–41.PubMedGoogle Scholar
  119. Selewski DT, Cornell TT, Heung M, Troost JP, Ehrmann BJ, Lombel RM, et al. Validation of the KDIGO acute kidney injury criteria in a pediatric critical care population. Intensive Care Med. 2014;40(10):1481–8.PubMedGoogle Scholar
  120. Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2007;18(8):2392–400.PubMedGoogle Scholar
  121. Shaikh N, Morone NE, Lopez J, Chianese J, Sangvai S, D'Amico F, et al. Does this child have a urinary tract infection? JAMA. 2007;298(24):2895–904.PubMedGoogle Scholar
  122. Shaikh N, Morone NE, Bost JE, Farrell MH. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J. 2008;27(4):302–8.PubMedGoogle Scholar
  123. Shaikh N, Ewing AL, Bhatnagar S, Hoberman A. Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics. 2010;126(6):1084–91.PubMedGoogle Scholar
  124. Shaikh N, Hoberman A, Keren R, Gotman N, Docimo SG, Mathews R, et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics. 2016;137(1):26647376.Google Scholar
  125. Shima Y, Nakanishi K, Hama T, Mukaiyama H, Togawa H, Sako M, et al. Spontaneous remission in children with IgA nephropathy. Pediatr Nephrol. 2013;28(1):71–6.PubMedGoogle Scholar
  126. Sims Sanyahumbi A, Colquhoun S, Wyber R, Carapetis JR. Global disease burden of group a Streptococcus. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: basic biology to clinical manifestations. Oklahoma City, OK: NCBI Shelf; 2016.Google Scholar
  127. Singh-Grewal D, Macdessi J, Craig J. Circumcision for the prevention of urinary tract infection in boys: a systematic review of randomised trials and observational studies. Arch Dis Child. 2005;90(8):853–8.PubMedPubMedCentralGoogle Scholar
  128. Skoog SJ, Peters CA, Arant BS Jr, Copp HL, Elder JS, Hudson RG, et al. Pediatric vesicoureteral reflux guidelines panel summary report: clinical practice guidelines for screening siblings of children with vesicoureteral reflux and neonates/infants with prenatal hydronephrosis. J Urol. 2010;184(3):1145–51.PubMedGoogle Scholar
  129. Smellie JM, Poulton A, Prescod NP. Retrospective study of children with renal scarring associated with reflux and urinary infection. BMJ. 1994;308(6938):1193–6.PubMedPubMedCentralGoogle Scholar
  130. Staples A, LeBlond R, Watkins S, Wong C, Brandt J. Validation of the revised Schwartz estimating equation in a predominantly non-CKD population. Pediatr Nephrol. 2010;25(11):2321–6.PubMedGoogle Scholar
  131. Subcommittee on Urinary Tract Infection SCoQI, Management, Roberts KB. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics. 2011;128(3):595–610.Google Scholar
  132. Sutherland SM, Zappitelli M, Alexander SR, Chua AN, Brophy PD, Bunchman TE, et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis. 2010;55(2):316–25.PubMedGoogle Scholar
  133. Sutherland SM, Ji J, Sheikhi FH, Widen E, Tian L, Alexander SR, et al. AKI in hospitalized children: epidemiology and clinical associations in a national cohort. Clin J Am Soc Nephrol. 2013;8(10):1661–9.PubMedPubMedCentralGoogle Scholar
  134. Sutherland SM, Byrnes JJ, Kothari M, Longhurst CA, Dutta S, Garcia P, et al. AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions. Clin J Am Soc Nephrol. 2015;10(4):554–61.PubMedPubMedCentralGoogle Scholar
  135. Symons JM, Chua AN, Somers MJ, Baum MA, Bunchman TE, Benfield MR, et al. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol. 2007;2(4):732–8.PubMedGoogle Scholar
  136. Thomas ME, Blaine C, Dawnay A, Devonald MA, Ftouh S, Laing C, et al. The definition of acute kidney injury and its use in practice. Kidney Int. 2015;87(1):62–73.PubMedGoogle Scholar
  137. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367(25):2407–18.PubMedPubMedCentralGoogle Scholar
  138. Tullus K. Vesicoureteric reflux in children. Lancet. 2015;385(9965):371–9.PubMedGoogle Scholar
  139. Vanmassenhove J, Vanholder R, Nagler E, Van Biesen W. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant. 2013;28(2):254–73.PubMedGoogle Scholar
  140. Verbitsky M, Sanna-Cherchi S, Fasel DA, Levy B, Kiryluk K, Wuttke M, et al. Genomic imbalances in pediatric patients with chronic kidney disease. J Clin Invest. 2015;125(5):2171–8.PubMedPubMedCentralGoogle Scholar
  141. Vivante A, Hildebrandt F. Exploring the genetic basis of early-onset chronic kidney disease. Nat Rev Nephrol. 2016;12(3):133–46.PubMedPubMedCentralGoogle Scholar
  142. Walters S, Porter C, Brophy PD. Dialysis and pediatric acute kidney injury: choice of renal support modality. Pediatr Nephrol. 2009;24(1):37–48.PubMedGoogle Scholar
  143. Wan J, Skoog SJ, Hulbert WC, Casale AJ, Greenfield SP, Cheng EY, et al. Section on Urology response to new guidelines for the diagnosis and management of UTI. Pediatrics. 2012;129(4):e1051–3.PubMedGoogle Scholar
  144. Warady BA, Abraham AG, Schwartz GJ, Wong CS, Munoz A, Betoko A, et al. Predictors of rapid progression of glomerular and nonglomerular kidney disease in children and adolescents: the chronic kidney disease in children (CKiD) cohort. Am J Kidney Dis. 2015;65(6):878–88.PubMedPubMedCentralGoogle Scholar
  145. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15(2):241–50.PubMedGoogle Scholar
  146. Weiss PF, Feinstein JA, Luan X, Burnham JM, Feudtner C. Effects of corticosteroid on Henoch-Schonlein purpura: a systematic review. Pediatrics. 2007;120(5):1079–87.PubMedPubMedCentralGoogle Scholar
  147. Welch WP, Yang W, Taylor-Zapata P, Flynn JT. Antihypertensive drug use by children: are the drugs labeled and indicated? J Clin Hypertens (Greenwich). 2012;14(6):388–95.Google Scholar
  148. Workgroup KA. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1–138.Google Scholar
  149. Working Group of the International Ig ANN, the Renal Pathology S, Roberts IS, Cook HT, Troyanov S, Alpers CE, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76(5):546–56.Google Scholar
  150. Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;368(25):2402–14.PubMedGoogle Scholar
  151. Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Palatnik LP, et al. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents. 2005;26(5):380–8.PubMedGoogle Scholar
  152. Zorc JJ, Levine DA, Platt SL, Dayan PS, Macias CG, Krief W, et al. Clinical and demographic factors associated with urinary tract infection in young febrile infants. Pediatrics. 2005;116(3):644–8.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Section of Pediatric Nephrology, Department of PediatricsUniversity of Missouri – Kansas City School of Medicine, Children’s Mercy Hospital and ClinicsKansas CityUSA
  2. 2.Division of Nephrology, Department of Pediatrics, McGill University Health CenterMontreal Children’s HospitalQCCanada

Personalised recommendations